Medicinal Products

Darzalex

Name Darzalex
Active Substance daratumumab
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code L01XC24
Medicinal product marketed in the Croatia Da
Educational materials
for healthcare professionals
Razumijevanje i ublažavanje interferencije daratumumaba, verzija 1
Razumijevanje interferencije daratumumaba Vodič za liječnike, verzija 1
Educational materials
for patients / caregivers
Kartica za bolesnike, verzija 1

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/darzalex

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o riziku od reaktivacije virusa hepatitisa B kod primjene lijeka Darzalex 19.06.2019 Janssen-Cilag International N.V.
Back